EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 56 / No 1 (March 2024) J Extra Corpor Technol, 56 1 (2024) 20-29 References
Open Access
Review
Issue
J Extra Corpor Technol
Volume 56, Number 1, March 2024
Page(s) 20 - 29
DOI https://doi.org/10.1051/ject/2023047
Published online 15 March 2024
  1. Kumar G, Maskey A. Anticoagulation in ECMO patients: an overview. Indian J Thorac Cardiovasc Surg. 2021;37:241–247. [CrossRef] [PubMed] [Google Scholar]
  2. Irby K, Swearingen C, Byrnes J, Bryant J, Prodhan P, Fiser R. Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: a retrospective pediatric study. Pediatr Crit Care Med. 2014;15(4):e175–e182. [CrossRef] [PubMed] [Google Scholar]
  3. Genty T, Burguburu S, Imbert A, Roman C, Camille W, Thès J, Stéphan F. Circuit change during extracorporeal membrane oxygenation: single-center retrospective study of 48 changes. Critical Care. 2023;27(1):1–6. [CrossRef] [PubMed] [Google Scholar]
  4. Lubnow M, Philipp A, Dornia C, et al. D-dimers as an early marker for oxygenator exchange in extracorporeal membrane oxygenation. J Crit Care. 2014;29(3):473–e1. [Google Scholar]
  5. Basken R, Cosgrove R, Malo J, et al. Predictors of oxygenator exchange in patients receiving extracorporeal membrane oxygenation. J Extra Corpor Technol. 2019;51(2):61. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Worku ET, Win AM, Parmar D, Anstey C, Shekar K. Haematological trends and transfusion during adult extracorporeal membrane oxygenation: a single centre study. J Clin Med. 2023;12(7):2629. [CrossRef] [PubMed] [Google Scholar]
  7. Doyle AJ, Hunt BJ. Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front Med. 2018;12(5):352. [CrossRef] [Google Scholar]
  8. Mansour A, Flecher E, Schmidt M, et al. Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study. Intensive Care Med. 2022;48(8):1039–1052. [CrossRef] [PubMed] [Google Scholar]
  9. Epis F, Belliato M. Oxygenator performance and artificial-native lung interaction. J Thorac Dis. 2018;10(Suppl 5):S596. [CrossRef] [PubMed] [Google Scholar]
  10. Belliato M, Degani A, Buffa A, et al. A brief clinical case of monitoring of oxygenator performance and patient-machine interdependency during prolonged veno-venous extracorporeal membrane oxygenation. J Clin Monit Comput. 2017;31:1027–1033. [CrossRef] [PubMed] [Google Scholar]
  11. Dufour N, Radjou A, Thuong M. Hemolysis and plasma free hemoglobin during extracorporeal membrane oxygenation support: from clinical implications to laboratory details. ASAIO J. 2020;66(3):239–246. [CrossRef] [PubMed] [Google Scholar]
  12. Omar HR, Mirsaeidi M, Socias S, et al. Plasma free hemoglobin is an independent predictor of mortality among patients on extracorporeal membrane oxygenation support. PLoS One. 2015;10(4), e0124034. [CrossRef] [PubMed] [Google Scholar]
  13. Pan KC, McKenzie DP, Pellegrino V, Murphy D, Butt W. The meaning of a high plasma free haemoglobin: retrospective review of the prevalence of haemolysis and circuit thrombosis in an adult ECMO centre over 5 years. Perfusion. 2016;31(3):223–231. [CrossRef] [PubMed] [Google Scholar]
  14. Valladolid C, Yee A, Cruz MA. von Willebrand factor, free hemoglobin and thrombosis in ECMO. Front Med. 2018;17(5):228. [CrossRef] [Google Scholar]
  15. Hazboun RG, Darwish N, Rotyliano-Sykes G, et al. Predictors of circuit health in neonatal patients receiving extracorporeal membrane oxygenation (ECMO). Sci Rep. 2022;12(1):1265. [CrossRef] [PubMed] [Google Scholar]
  16. Neal JR, Quintana E, Pike RB, Hoyer JD, Joyce LD, Schears G. Using daily plasma-free hemoglobin levels for diagnosis of critical pump thrombus in patients undergoing ECMO or VAD support. J Extra Corpor Technol. 2015;47(2):103. [PubMed] [Google Scholar]
  17. Appelt H, Philipp A, Mueller T, et al. Factors associated with hemolysis during extracorporeal membrane oxygenation (ECMO) – Comparison of VA – versus VV ECMO. PLOS ONE [Internet]. 2020;15(1):e0227793. [CrossRef] [Google Scholar]
  18. Dornia C, Philipp A, Bauer S, et al. D-dimers are a predictor of clot volume inside membrane oxygenators during extracorporeal membrane oxygenation. Artif Organs. 2015;39(9):782–787. [CrossRef] [PubMed] [Google Scholar]
  19. Shakoor A, Chen S, Hyde J, et al. Utility of D-dimers in COVID-19 patients requiring extracorporeal membrane oxygenation. ASAIO J. 2022;68(10):1241. [CrossRef] [PubMed] [Google Scholar]
  20. Balle CM, Jeppesen AN, Christensen S, Hvas AM. Platelet function during extracorporeal membrane oxygenation in adult patients. Front Cardiovasc Med. 2019;8(6):114. [CrossRef] [PubMed] [Google Scholar]
  21. Chegondi M, Vijayakumar N, Badheka A, Karam O. Effect of platelet transfusions on extracorporeal life support oxygenator’s function. Front Pediatr. 2022;7(10):826477. [CrossRef] [PubMed] [Google Scholar]
  22. Balle CM, Jeppesen AN, Christensen S, Hvas AM. Platelet function during extracorporeal membrane oxygenation in adult patients: a systematic review. Front Cardiovasc Med. 2018;9(5):157. [CrossRef] [PubMed] [Google Scholar]
  23. Winnersbach P, Rossaint J, Buhl EM, et al. Platelet count reduction during in vitro membrane oxygenation affects platelet activation, neutrophil extracellular trap formation and clot stability, but does not prevent clotting. Perfusion. 2022;37(2):134–143. [CrossRef] [PubMed] [Google Scholar]
  24. Steiger T, Foltan M, Philipp A, et al. Accumulations of von Willebrand factor within ECMO oxygenators: Potential indicator of coagulation abnormalities in critically ill patients? Artif Organs. 2019;43(11):1065–1076. [CrossRef] [PubMed] [Google Scholar]
  25. Zakhary B, Vercaemst L, Mason P, Antonini MV, Lorusso R, Brodie D. How I approach membrane lung dysfunction in patients receiving ECMO. Crit Care. 2020;24:1–4. [CrossRef] [PubMed] [Google Scholar]
  26. Sarathy S, Turek JW, Chu J, Badheka A, Nino MA, Raghavan ML. Flow monitoring of ECMO circuit for detecting oxygenator obstructions. Ann Biomed Eng. 2021;49:3636–3646. [CrossRef] [PubMed] [Google Scholar]
  27. McBane RD II, Roldan VD, Niven AS, et al. Anticoagulation in COVID-19: a systematic review, meta-analysis, and rapid guidance from Mayo Clinic. Mayo Clinic Proc. 2020;95(11):2467–2486. Elsevier. [CrossRef] [Google Scholar]
  28. Chlebowski MM, Baltagi S, Carlson M, Levy JH, Spinella PC. Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO. Critical Care 2020;24:1–2. [CrossRef] [PubMed] [Google Scholar]
  29. Song K, Kim JB. Safety of low-dose anticoagulation in extracorporeal membrane oxygenation using the Permanent Life Support System: a retrospective observational study. J Yeungnam Med Sci 2023;40(3):276–282. [CrossRef] [PubMed] [Google Scholar]
  30. Ratzlaff RA, Ripoll JG, Kassab LL, Diaz-Gomez JL. Acute oxygenator failure: a new presentation of heparin-induced thrombocytopenia in a patient undergoing venovenous extracorporeal membrane oxygenation support. Case Rep. 2016;16(2016):bcr2016218179. [Google Scholar]
  31. Burstein B, Wieruszewski PM, Zhao YJ, Smischney N. Anticoagulation with direct thrombin inhibitors during extracorporeal membrane oxygenation. World J Crit Care Med. 2019;8(6):87. [CrossRef] [PubMed] [Google Scholar]
  32. M’Pembele R, Roth S, Metzger A, et al. Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis. Thrombosis J. 2022;20(1):1–9. [Google Scholar]
  33. Geli J, Capoccia M, Maybauer DM, Maybauer MO. Direct thrombin inhibition in extracorporeal membrane oxygenation. Int J Artif Organs. 2022;45(7):652–655. [CrossRef] [PubMed] [Google Scholar]
  34. Neunert C, Chitlur M, Van Ommen CH. The changing landscape of anticoagulation in pediatric extracorporeal membrane oxygenation: use of the direct thrombin inhibitors. Front Med. 2022;6(9):887199. [CrossRef] [Google Scholar]
  35. Siddiqui NA, Dominguez A, Sharma A, Conrad SA. Technique for circuit exchange in high-risk patients on extracorporeal life support. Perfusion 2023;38(5):963–5. [CrossRef] [PubMed] [Google Scholar]
  36. Da Broi U, Adami V, Falasca E, Malangone W, Crini S, Degrassi A. A new oxygenator change-out system and procedure. Perfusion. 2006;21(5):297–303. [CrossRef] [PubMed] [Google Scholar]
  37. McMichael AB, Ryerson LM, Ratano D, Fan E, Faraoni D, Annich GM. 2021 ELSO adult and pediatric anticoagulation guidelines. ASAIO J. 2022;68(3):303–310. [CrossRef] [PubMed] [Google Scholar]
  38. Zeibi Shirejini S, Carberry J, McQuilten ZK, Burrell AJ, Gregory SD, Hagemeyer CE, Current and future strategies to monitor and manage coagulation in ECMO patients. Thrombosis J. 2023;21(1):1–20. [CrossRef] [Google Scholar]
  39. Delmas C, Jacquemin A, Vardon-Bounes F, et al. Anticoagulation monitoring under ECMO support: a comparative study between the activated coagulation time and the anti-Xa activity assay. J Intensive Care Med. 2020;35(7):679–686. [CrossRef] [PubMed] [Google Scholar]
  40. Bercovitz RS. An introduction to point-of-care testing in extracorporeal circulation and LVADs. Hematology 2018;2018(1):516–521. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.